New ContractToday's news release, while relatively small in announced size, is very encouraging. Getting a large global pharma company to come on board is a validation of the business models potential. Typically clients start with a small contract trial period (which is why this one ends after 2023) before expanding their use of the service. Significant operating leverage with these types of deals which means most of that revenue will flow to the bottom line.